OpGen Inc (OPGN)

[chillswills37]

Proxy vote info here. Voting NO sends a strong message of no confidence and lays groundwork for further shareholder action in respect to comportment of the B.O.D. including CEO Ollie Schacht and Chairman Bill Rhodes. OpGen biotechnology, patents, and ARESdb (Ares database) are worth XX scores of millions of dollars in a buyout or takeover. However, the B.O.D. and upper management, overcompensated to the hilt, have failed their shareholders, miserably so. The gang directing this show are unmitigated disasters and undeserving of election much less compensation. For what? 50 cents a share? Send these leeches and non-performers packing.

$OPGN Shareholders of record date 14 April 2022 can vote. 1 share = 1 vote.

The presence in person or by proxy of the holders of thirty four percent (34%) of the outstanding common stock is necessary to constitute a quorum at the Annual Meeting. As of the record date of April 14, 2022, there were 46,557,750 shares of our common stock outstanding, representing the same number of votes. Accordingly, 23,278,876 shares of our common stock will be required to establish a quorum. Abstentions and broker non-votes, if any, are counted as present for determining the presence of a quorum. .

https://www.shareholdereducation.com/proxy-voting-frequently-asked-questions

https://fintel.io/doc/sec-opgen-inc-1293818-def-14a-2022-april-25-19107-1229

NO to All Proposal 1: Election of Directors. The nominees for election as directors at the Annual Meeting will be elected by the vote of a plurality of the shares of our common stock entitled to vote on the election, represented in person or by proxy at the Annual Meeting. This means the director nominees receiving the highest number of affirmative votes will be elected as directors. Votes withheld from a director nominee will have no effect on the election of the director from whom votes are withheld.

NO Proposal 2: Approval of Reverse Stock Split Proposal. Pursuant to our Certificate, the reverse stock split proposal requires the affirmative vote of at least a majority of the outstanding shares of common stock of the Company.

NO Proposal 3: Ratification of CohnReznick's Appointment. The ratification of the appointment of CohnReznick as our independent registered public accounting firm for the 2022 fiscal year requires the affirmative vote of a majority of the votes cast by all stockholders present in person or represented by proxy at the Annual Meeting and entitled to vote on the proposal. If the selection of CohnReznick as our independent registered public accounting firm is not ratified, the Audit Committee of the Board may reconsider its selection.

Proposal 4: Adjournment. The approval of the adjournment requires the affirmative vote of a majority of the votes cast by all stockholders present in person or represented by proxy at the Annual Meeting and entitled to vote on the proposal.

Directors
NO William E. Rhodes, III 68 Chairman of the Board of Directors
NO Mario Crovetto 69 Director
NO R. Donald Elsey 69 Director
NO Prabhavathi Fernandes, Ph.D. 73 Director
NO Oliver Schacht, Ph.D. 51 Chief Executive Officer and Director

Other Executive Officers
NO Albert Weber 58 Chief Financial Officer and Corporate Secretary
NO Johannes Bacher 53 Chief Operating Officer